Cut psoriasis biologic spend by >50%
Solay Health specializes in a modernized Goeckerman regimen. For the first time, this highly effective, biologic-sparing therapy is accessible to members at home.
Biologics are driving unsustainable spend.
Psoriasis affects about 3% of adults, but it's one of the largest drivers of specialty pharmacy spend.
Plaque psoriasis treatment averages $47,125 per member per year in net cost. And once a member starts a biologic, they rarely come off it.
Use the calculator to estimate your annual psoriasis biologic spend.
Biologic spend estimator
We estimate you are spending this on psoriasis biologics each year.
Assumptions and sources
- 3% of adults have psoriasis National Psoriasis Foundation
- 30% of those have moderate-to-severe disease Danish Skin Cohort, 2023
- 20% of those are treated with a biologic Scientific Reports, 2024
- $47,125 average net cost per member, per year JAMA Dermatology, 2025
Solay's modernized Goeckerman regimen is highly effective, biologic-sparing, and very safe.
| Psoriasis Treatment | Efficacy | Safety Profile | Annual Cost | Systemic Risk | Remission |
|---|---|---|---|---|---|
| Topicals | Low | Good | < $5K | Moderate | Short |
| UVB alone | ~40% | Excellent | < $5K | None | Moderate |
| Biologics | > 90% | Moderate | ~$47K | High | Ongoing use |
| Solay(Goeckerman) | > 90% | Excellent | ~$5K | None | ~1 year |
Solay solves three problems in psoriasis care.
Problem
Poor Access
Dermatology clinics often have long wait times to be seen.
With Solay
Personalized, 24/7 Access
Members can easily book virtual appointments and message their care team.
Problem
Premature Escalation
When topicals fail, patients go straight to biologics — because Goeckerman therapy has never been accessible.
With Solay
Biologic-sparing
Goeckerman clears skin without systemic immunosuppression — so members can delay or avoid biologics altogether.
Problem
High Costs
Specialty drugs for psoriasis are a high cost driver for health plans.
With Solay
Fraction of the Cost
Compared to leading biologic medications, health plans save 89% on psoriasis care with Solay.
Why partner with Solay
Biologics and topicals drive the majority of psoriasis-related healthcare costs. Solay offers a safe, evidence-based alternative that can prevent or delay the need for biologics, while achieving similar outcomes.
Solay offers flexible risk- and value-based contracts, including monthly pricing — so you pay only while a member is actively in treatment and enrolled with you.
Our patients report significant improvements in skin clearance, symptom control, and quality of life. We track validated metrics to demonstrate those improvements.
Members receive easy access to clinical support, real-time dose adjustments, and personalized education.
The standard dermatology care model isn't built for a treatment that requires frequent, high-touch monitoring — but Solay Health is.
Solay helps members achieve and sustain long-term remission through structured, ongoing care management.
Virtual consultation with our dermatologists.
Complete treatment kit, delivered.
Continuous monitoring and treatment adjustments.
Support that continues through remission.
Let's partner together
Solay operates under board-supervised dermatologists and integrates easily into existing care management ecosystems. Tell us about your plan and we'll be in touch to discuss pilot programs or bundled-care, value-based models.